D-Dimer Inhibitors
D-Dimer is a protein fragment that plays a crucial role in the process of blood coagulation and fibrinolysis. It is formed as a result of the breakdown of cross-linked fibrin clots by the action of plasmin, an enzyme responsible for fibrinolysis. D-Dimer serves as a biomarker for the presence of blood clots in the body, with elevated levels often indicating the presence of thrombotic disorders such as deep vein thrombosis, pulmonary embolism, or disseminated intravascular coagulation. Its function lies in the detection and dissolution of fibrin clots, contributing to the regulation of hemostasis and the disruption of excessive clot formation.
Inhibition of D-Dimer involves the disruption of its formation or activity within the blood coagulation and fibrinolysis cascade. Mechanistically, inhibition may occur at various points along the pathway leading to fibrin clot formation or its subsequent breakdown. Strategies for inhibiting D-Dimer may include targeting enzymes involved in the fibrinolytic process, such as plasmin or its activators, to stop the breakdown of fibrin clots and the subsequent release of D-Dimer fragments. Additionally, inhibition may also involve targeting factors involved in the initial stages of blood clot formation, such as fibrinogen or thrombin, to hinder the generation of fibrin clots and subsequent D-Dimer release. Overall, inhibition of D-Dimer represents an approach for managing thrombotic disorders by modulating the blood coagulation and fibrinolysis pathways.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
It could reduce protein synthesis by inhibiting the mTOR pathway, which is involved in cell growth and proliferation. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
By inhibiting dihydrofolate reductase, it can suppress DNA synthesis and, consequently, protein expression. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
It inhibits thymidylate synthase, which can lead to a reduction in nucleotide synthesis and potentially lower protein expression. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
This compound inhibits eukaryotic protein synthesis by preventing translocation steps in the ribosome. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
It intercalates into DNA, preventing RNA synthesis and thus inhibiting protein expression. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
By stabilizing microtubules, it disrupts cell division, which could indirectly lower protein levels, including avidin. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can reduce the degradation of regulatory proteins, potentially affecting overall protein expression. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
It has been shown to inhibit the transcription of RNA, which would reduce protein synthesis globally. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
It can alter the endosomal and lysosomal pH, possibly affecting the post-translational modification of proteins. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Inhibits ribonucleotide reductase, leading to reduced DNA synthesis and, subsequently, protein expression. | ||||||